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Abstract Two isoforms of mammalian cytochrome bs, which 
have homologous cytosolic amino-terminal catalytic domains, are 
located one on endoplasmic reticulum (ER bs) the other on mito- 
chondrial outer membranes (OM bs). A eDNA coding for the 
previously unknown carboxyl-terminal domain of OM bs was 
cloned and a chimera between the catalytic domain of ER bs and 
the carhoxyl-terminal region of OM bs was expressed in cultured 
mammlian cells. The chimera localized to mitochondria, indicat- 
ing that the carhoxyl-terminal 43 amino acids of OM bs contain 
sufficient information to target the catalytic domain of ER bs to 
the mitochondrial outer membrane. 
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1. Introduction 
During the past few years there has been increasing interest 
in the mechanism of targeting of a class of membrane proteins 
characterized by an N-terminal cytosolic domain and a short 
C-terminal anchoring domain. These proteins, which have re- 
cently been called 'tail-anchored' [I], lack a signal sequence and 
are inserted into membranes post-translationally. Current evi- 
dence favours a transmembrane topology for their membrane 
anchor [1,2]. Members of this class of proteins are involved in 
fundamental processes within the cell, such as vesicular traffic 
(t-snares and v-snares), regulation of apoptosis (bcl-2), tyrosine 
dephosphorylation (PTB-1B), electron transport (cyt bs) [1,3] 
and references therein). 
Although it was previously thought hat tail-anchored pro- 
teins could insert non-specifically into any phospholipid bi- 
layer, it is now known that many of them have restricted and 
specific subcellular distributions, and it is thought that un- 
known targeting mechanisms are responsible for their localiza- 
tion (see [3] and [4] tbr reviews). As a starting point for thinking 
about the targeting mechanisms of tail-anchored proteins, two 
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general models can be considered. In the first one, the cytosolic 
active domain, by interacting permanently or transiently with 
specifically located protein partners, determines, in addition to 
the function of the protein, also its localization. In this scenario, 
the C-terminal anchoring domain would have a non-specific 
role in the integration of the protein into the phospholipid 
bilayer. In the second model, information for targeting would 
be distinct from the structural features required for function, 
and could be located within the C-terminal anchoring domain. 
A system which could allow the distinction between these 2 
mechanisms i  offered by the 2 homologous isoforms of cyto- 
chrome (cyt) bs. Mammalian tissues express an endoplasmic 
reticulum (ER)-bound cyt b5 (ER bs) and an mitochondrial 
outer membrane isoform (called outer membrane cyt b by the 
group that discovered it [5], and which we will refer to as OM 
bs), which are the products of 2 different genes [6]. ER b5 
consists of an N-terminal, heme-binding, cytosolic domain, 
which can be detached by trypsin from the C-terminal anchor- 
ing domain. The latter includes: (i) a polar hinge region, which 
connects the anchor to the cytosolic domain; (ii) the membrane 
anchor itself; and (iii) the polar residues located at the extreme 
C-terminus. As far as OM b5 is concerned, until the present, 
only the primary structure of a tryptic fragment, corresponding 
to the cytoslic, heme-containing, domain had been determined 
[6]. The sequence of this domain is 60% identical to the corre- 
sponding region of ER bs. Since OM b5 has a higher apparent 
Mr than the sequenced tryptic fragment and behaves like an 
integral membrane protein [7], it was anticipated that it would 
have a membrane-anchoring domain, however, it was not 
known whether this domain was at the C- or N-terminus of the 
protein. 
In a previous tudy, by using monospecific anti-peptide anti- 
bodies, we demonstrated that the 2 cyt b5 isoforms have non- 
overlapping subcellular distributions and are each located ex- 
clusively, or nearly exclusively, on a single target membrane [7]. 
Homologous proteins with different subcellular localizations 
are good models for the study of intracellular targeting, because 
the regions which are less similar between them are good candi- 
dates for targeting signals, and because it is possible to con- 
struct chimerae which are likely to retain the native structure 
of the wild-type parent proteins. We report here the finding that 
the anchoring domain of OM b5 is C-terminal and that the 
information contained therein is sufficient o target the cy- 
tosolic domain of ER b5 to the mitochondrial outer membrane. 
Abbreviations. cyt, cytochrome; ER, endoplasmic reticulum; ER bs, 
endoplasmic reticulum isoform of cytochrome bs; NER-COM, chimera 
between N-terminal domain of ER b5 and C-terminal domain of OM 
bs; OM b~, outer mitochondrial membrane isoform of cytochrome bs; 
PDI, protein disulphide isomerase. 
2. Materials and methods 
2.1. General 
Recombinant DNA techniques were carried out by standard proce- 
dures [8,9]. DNA sequencing was carried out by the dideoxy chain 
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termination method on inserts cloned in pGEM 3 (Promega, Madison, 
WI), using the Taq Track kit from Promega. 
2.2. Cloning of cDNA jbr OM b~ by anchoredpolymerase chain reaction 
(PCR) 
A 200 bp cDNA fragment coding for a portion of the cytosolic 
domain of OM b5 was amplified from rat liver cDNA. The latter was 
obtained by reverse transcription of 5 pg total rat liver RNA, prepared 
by the method of [10], using random hexanucleotides as primers. To 
amplify this cDNA, 2 oligonucleotides were designed from the known 
primary structure of the cytosolic domain of OM b5 [6]: 5' oligonucleo- 
tide: 5' CGGGATCCAACACTGCTGAGG-AGACCTGGATGGTG- 
ATCCA 3'; 3' oligonucleotide: 5"GCGGTACCG-TCATTGGGGAC- 
ATCCCCAATGTAGTACTGCTT 3'. The 5' and 3' oligonucleotides 
each contained an extra-sequence (in italics) with a BamHI and KpnI 
site, respectively. The amino acid sequences used for the construction 
of these oligonucleotides are overlined with dashed arrows in Fig. 1A. 
The cDNA (deriving from 1/4 of the total) was amplified for 30 cycles 
(94°C, 1 min; 58°C, 1.5 min; 72°C, 1 min 10 min in the final cycle) 
in a standard buffer containing 1.5 mM MgC12. 1/10 of the reaction mix 
was reamplified under the same conditions. The amplified DNA was 
purified, cut with KpnI and BamH1, and subcloned into pGEM 3. The 
sequence of 2 separate clones were in agreement with each other and pre- 
dicted the expected amino acid sequence previously determined by [6]. 
To obtain a clone specifying the previously unkown C-terminal por- 
tion of OM bs, the RACE-PCR protocol [11] was applied, using a 
sequence internal to the previous clone as 5' primer, and dTll7 ) extended 
by an adaptor sequence containing restriction sites, as well as the 
adaptor sequence alone, as 3' primer. The sequence of the 5' primer 
(overlined by solid arrow in Fig. IA) was: GAGTCTACGATAT- 
CACCCG. Rat liver cDNA was obtained from total RNA as described 
above but using the dT~7)-adaptor instead of random hexanucleotides 
as primer. 1/10 of the cDNA was amplified with the primers described 
above for 30 cycles (94°C, 1 min; 55°C, 2 min; 72°C, 1 min - 10 min 
in the final cycle). After purification, the amplified DNA was cut within 
sites present in the adaptor (SalI) and in the known part of the amplified 
fragment (HindlIl, at position 91 in Fig. 1A), and subcloned into 
pGEM 3.3 positive clones, selected by colony hybridization with the 
200 bp probe, were sequenced. 
2.3. Construction of 'NER-COM" chimera 
A chimeric DNA coding for the first 91 residues of ER b5 joined to 
residues 93 134 of OM b 5 (Fig. 1A and B) was constructed taking 
advantage of a unique PvuI site present in ER b5 cDNA at the junction 
between codons 87 and 88. 
The synthetic DNA for ER bs, [12], a gift of Dr. Stephen Sligar, 
University of Illinois, was recloned into the PstI-EcoRI sites of pGEM 
3. A ~300 bp fragment, coding for the first 87 residues of ER b 5 was 
excised with HindIlI (within the polylinker, upstream of the cloning 
site) and Pvul (at the junction between codons 87 and 88), and purified. 
A fragment of the cDNA for OM b 5, coding for residues 93-134 
was amplified with a 5' primer comprising the desired junction between 
the 2 clones, and containing the PvuI site of ER b5 (5"AT 
CGATCGTTCTAAAGATGGTGACAAGGACCCT 3': bases in ital- 
ics are extrasequence; underlined bases contain ER b5 sequence) and a 
3' primer extending from 5 to 20 nts downstream to the stop codon (5' 
GGAA TTCCGACACTTCAACGTGGC 3' bases in italics are extra- 
sequence containing an EcoRI site). The amplified fragment was puri- 
fied, digested with PvuI and EcoRI, and ligated together with the 
HindlII-PvuI fragment deriving from ER b5 into pGEM 3 cut with 
HindIII and EcoRI. The absence of errors due to amplification was 
controlled by sequencing. 
2.4. TramJbction of CV1 cells 
The cDNAs coding for ER b 5 and for the NER-COM chimera were 
subloned into the HindII1 and EcoRI site of the mammalian expression 
vector pCB6 [13], modified to contain an EeoRI site within the 
polylinker. 
Cells, plated on 1.7 × 1.7 cm glass coverslips, were transfected by the 
calcium phosphate method [14], but the glycerol shock was omitted. 
Uptake of DNA was increased by post-incubation f the cells with 0.1 
mM chloroquine in complete medium for 3 h. 24 h after transfection, 
cells were fixed with 4% paraformaldehyde in 0.120 M sodium phos- 
phate buffer, pH 7.4, at 37°C for 30 min. 
2.5. Antibodies and immunofluorescence 
Coverslips containing the paraformaldehyde-fixed cells were washed 
in HS (0.5 M NaC1, 20 mM sodium phosphate buffer pH 7.4) and 
preincubated for 1 h on a drop of blocking buffer (= HS containing 
0.2% gelatin and 0.6% Triton X-100). The coverslips were then incu- 
bated for 2 h with primary antibody diluted in blocking buffer, washed 
briefly 5 times with HS, incubated for 1 h with fluorescent secondary 
antibodies diluted in blocking buffer, washed again 5 times with HS and 
once with PBS, mounted in PBS containing 70% glycerol and 0.1% 
phenylenediamine, and observed under a Zeiss Axioplan microscope 
equipped for epiftuorescence. In some experiments, the signal was am- 
plified by use of biotinylated secondary antibodies followed by strep- 
tavidin-Texas red (Amersham, Buckinghamshire, UK). In this case, 2 
blocking steps were carried out with the reagents of the blocking kit 
from Vector Laboratories (Burlingame, CA). 
Primary antibodies used were: (i) a polyclonal antibody raised in 
rabbits against a bacterially expressed fusion protein of rabbit ER bs. 
The cDNA for rabbit ER b5 [15], a gift of Dr. A. Steggles (Northeastern 
Ohio Universities College of Medicine), cut with FspI and Hindll was 
cloned into the filled BamHI site of pET3a (Novagen, Madison, WI). 
The resulting construct coded for a fusion protein consisting of the first 
1 ! residues of the gene 10 protein of phage T7, followed by residues 
3 134 of rabbit ER bs. The bacterially expressed fusion protein was 
enriched in a low speed pellet after lysis of bacteria with lysozyme and 
DNase treatment ofthe lysate. This crude preparation offusion protein 
was used as immunogen. The resulting anstiserum was affinity-purified, 
using a nitrocellulose strip containing the SDS-PAGE-purified fusion 
protein as affinity matrix [16]. The affinity purified antibodies were used 
at a dilution corresponding to 1:125 of the original antiserum; (ii) a 
monclonal antibody against bovine protein disulfide isomerase (PDI) 
from StressGen (Victoria, BC, Canada), used at 1:500 dilution. Second- 
ary antibodies were from Jackson Immunoresearch (West Grove, PA) 
or from Amersham (Buckinghamshire, UK). 
Mitochondria were stained with Mitotracker CMX Rose from Mo- 
lecular Probes (Eugene, OR). Cells were incubated with the dye dis- 
solved in the culture medium at a concentration f 800 nM for 15 min 
in the CO2 incubator, and then fixed with paraformaldehyde and proc- 
essed for immunofluorescence as described above. 
3. Results and discussion 
To clone the cDNA coding for the C-terminal port ion of OM 
bs, we first constructed a 200 nt long probe by amplification of 
reverse-transcribed liver RNA using as primers oligonucleo- 
tides designed on the basis of the known amino acid sequence 
- . . )  
Fig. 1. Primary structures and hydropathy plots of ER b 5 and OM bs, 
and construction of NER-COM chimera. (A) Upper line shows cDNA 
sequence derived from the 2 overlapping clones (200 bp probe and ~ 800 
bp clone obtained by RACE-PCR). The dashed arrows overline the 
regions used to design by reverse translation the oligonucleotides u ed 
for the initial cloning of the 200 bp probe; the continuous arrow indi- 
cates the oligonucleotide used for RACE-PCR (see section 2). The 
deduced amino acid sequence is given on the line marked 'OM' while 
the line marked 'ER'shows the primary sequence of rat ER b5 from [17]. 
The first 31 residues of OM bs, not encoded in our clones, are from [6] 
Residues 32-92, deduced from the cDNA, coincide with those deter- 
mined by [6] on the tryptic fragment of the protein. Alignment of ER 
b5 and OM b5 was done with the Align program [24]. Residues within 
black or grey boxes are identical or similar, respectively. The vertical 
arrow passing between residues 92 and 93 of OM b5 and between 
residues 90 and 91 of ER bs indicates the site of cleavage of trypsin. The 
open rectangle, close to the C-terminus of the 2 proteins, encloses an 
uninterrupted stretch of uncharged amino acids in both proteins. (B) 
Kyte-Doolittle hydropathy plot for OM b 5 and ER b 5 (window set- 
ting -- 7). The grey and open horizontal bars below the plots indicate 
the tryptic fragments of OM bs and ER b5 respectively, while the filled 
black and striped bars correspond to the respective C-terminal anchor- 
ing domains. The bar at the bottom of the panel schematizes the struc- 
ture of NER-COM and shows the amino acid sequence at the junction 
between the 2 domains in the chimera. 
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[6]. (Fig. 1A). The nucleotide sequence of the cloned fragment 
predicted the expected amino acid sequence. Since screening of 
several cDNA libraries with this probe gave negative results, 
we turned to a RACE-PCR protocol [11] to obtain the 3' por- 
tion of the cDNA for OM bs. An oligonucleotide corresponding 
to a sequence within the probe (overlined with full arrow in Fig. 
1A) was used as 5' primer to amplify liver cDNA together with 
an oligo(dT) 3' primer (see section 2). The resulting ~800 nt 
fragment was cloned and sequenced. The first part of the se- 
quence overlapped with that already determined in the 200 nt 
probe. The reading frame continued as expected from the 
amino acid sequence of [6] until the site of cleavage of trypsin 
at Lys-92 (vertical arrow), to continue with 43 codons followed 
by a stop codon (Fig. 1A). The additional 43 codons specified 
a polar linker region (residues 93-107), a hydrophobic region 
(residues 108 125, enclosed within the rectangle) and 10 resi- 
dues constituting a short polar region at the extreme C-termi- 
nus. 
Fig. 1A shows the nucleotide sequence of OM b5 cDNA 
determined from the 200 nt probe and the 5' portion of the 800 
nt fragment, as well as the amino acid sequence of the protein 
- from the work of [6] and deduced from the cDNA sequence 
of this study - aligned with that of rat ER b5 [17]. Panel B of 
the same figure shows the hydropathy plots for the 2 cyt b5 
isoforms. The 2 plots are quite similar, illustrating that the 2 
..J 
C 
proteins have hydrophobic tails of similar lengths and in similar 
positions. Although the hydropathy plots of the 2 proteins are 
similar, examination of Fig. 1A shows that the high degree of 
sequence similarity present in the N-terminal, trypsin-resistant, 
heme-binding domains (site of trypsin cleavage indicated by the 
vertical arrow), is lost in the C-terminal portion of the proteins. 
This is especially apparent in the linker regions, while the hy- 
drophobic stretch presents a higher percentage of conserved 
residues. 
To investigate whether targeting information ispresent in the 
heme-binding and/or in the anchoring domain of cyt b5 
isoforms, we constructed a chimera between the the N-terminal 
domain of ER b5 and the C-terminal domain of OM bs (NER- 
COM). The 2 domains were joined at the site of trypsin cleav- 
age, as shown in Fig. 1A and B. The wt ER b5 and NER-COM 
were expressed in transiently transfected CVI cells, and 24 h 
after transfection their localization was analyzed by im- 
munofluorescence, using an antibody against rabbit ER bs. The 
relatively short time allowed for expression of the exogenous 
DNA was chosen in order to avoid artifacts due to heavy 
overexpression. The results of these experiments are shown in 
Figs. 2 and 3. At the dilutions of antibody used, endogenous 
cyt b5 of CV1 cells was not detectable (see cells marked by 
asterisks in Figs. 2 and 3). As can be seen from Figs. 2a and 
3a, ER b5 showed a reticular staining pattern spread out 
Q 
$ 
J 
Fig. 2. Comparison of localization of ER b5 and NER-COM with that of mitochondria in transfected cells. CV1 cells transiently transfected with 
ER b5 (panels a and b) or with NER-COM (panels c and d), were incubated with Mitotracker CMX Rose, then fixed, permeabilized and stained 
for cytochrome bs. using FITC-labeled secondary antibodies. Panels a and b correspond to the same field of cells transfected with ER bs. observed 
for cyt b 5 (fluorescein filter - panel a) and for mitochondria (rhodamine filter - panel b). Panels c and d correspond tothe same field of cells transfected 
with NER-COM, viewed for cyt b5 (panel c) or for mitochondria (panel d). NER-COM and mitochondria precisely colocalize. Asterisks in all panels 
correspond to the positions of non-transfected cells, which give a positive stain for mitochondria but do not stain with anti-ER b5 antibodies. Bar 
in panel a = 10/~m. 
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through the cytoplasm and coinciding with the distribution of 
the ER marker PDI (compare Fig. 3a with Fig. 3b). Its distribu- 
tion was completely different from that of mitochondria, which 
appearsed as distinct, elongated organelles, revealed with a 
fluorescent mitochondrial stain (compare Fig. 2a and 2b). In 
sharp contrast, when its level of expression was not too high, 
NER-COM had a staining pattern precisely matching that of 
mitochondria (compare Fig. 2c and 2d) and not at all superim- 
posable on that of PDI (Fig. 3c and d). When levels of expres- 
sion were higher, some NER-COM was also present on the ER 
(not shown), suggesting that binding of the chimera to mito- 
chondria was saturable and that excess protein could associate 
with the ER. At yet higher levels of expression, especially in 
cells observed at later times after transfection, both ER b5 and 
NER-COM were concentrated in large bodies (diameters up to 
10 pm), probably corresponding toautophagic vacuoles, which 
accumulated around the nucleus (not shown). 
Our results indicate the presence of a targeting signal for OM 
b5 in the C-terminal anchoring domain of the protein, since this 
region is sufficient o relocate the cytosolic functional domain 
of ER b5 to the outer mitochondrial membrane. We do not yet 
know whether the targeting information iscontained within the 
membrane anchor itself or within the hydrophilic flanking se- 
quences, but we favour the latter possibility, since (i) the hydro- 
phobic stretch appears more conserved between the 2 isoforms 
than the polar flanking regions; (ii) changes in the sequence of 
the membrane anchor of ER b5 do not alter its subcellular 
localization, as judged by immunofluorescence of transfected 
cells (our unpublished results). 
Previous work had suggested a function in targeting for the 
C-terminal domain of ER cyt b5 [18] and of the ER form of 
aldehyde dehydrogenase (msALDH). [19]. For ER cyt b5 it was 
shown that in the absence of the 10 C-terminal amino acids, the 
protein failed to bind to the ER [18]. In the case of msALDH, 
deletion of residues from either of the regions flanking the 
anchor did not interfere with localization to the ER, while the 
double deletion of key residues from both these regions resulted 
in the protein remaining cytosolic [19]. In both these studies, 
the deletions caused the proteins to become soluble. Thus, the 
implicated sequences might be involved in the stabilization of 
the proteins in the membrane, rather than in their targeting. In 
contrast, the present work, which shows that the anchoring 
domain of OM b5 targets the cytosolic domain of ER b5 to an 
alternative membrane (the outer mitochondrial membrane), 
clearly demonstrates a role in targeting for the C-terminal re- 
gion. 
m 
Fig. 3. Comparison of localization of ER b 5 and NER-COM with that of PDI in transfected cells. CV 1 cells, transiently transfected with ER b5 (panels 
a and b) or NER-COM (panels c and d), were doubly immunostained for cyt b5 (panels a and c) or PDI (panels b and d). Panels a and b show the 
same field of cells transfected with ER bs, while panels cand d show the same field of cells transfected with NER-COM. ER b~ colocalizes with PDI, 
while NER-COM has a different pattern. Asterisks and bar are as in Fig. 2. 
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On the membrane of the ER, cyt b 5 interacts with a number 
of protein partners, including its electron acceptors, involved 
in various aspects of lipid and drug metabolism, and its electron 
donors, i.e. NADH-cyt b 5 reductase and NADPH-cyt P-450 
reductase. In all of these interactions, the same negatively 
charged surface area surrounding the exposed heme edge of cyt 
b5 appears to be involved, with formation of complementary 
charge pairs between carboxylate groups of that region and 
appropriately spaced amino groups at the surface of the various 
acceptors or donors (see [4] for a review). The present work 
shows that these protein-protein i teractions do not play a 
dominant role in cyt b5 targeting, since it can be relocated to 
a different membrane by a protein region distinct from the 
cytosolic heme-binding domain. Moreover, our results impli- 
cate the C-terminal region of OM b5 in targeting to the mito- 
chondrial outer membrane rather than an N-terminal amphipa- 
thic helix-forming sequence, as found in matrix-directed 
precursors [20]. It is of interest that a C-terminal mitochondrial 
outer membrane targeting signal has been reported also for 
monoamine oxidase B [21]. This protein appears however to be 
at least partially translocated into the intermembrane space 
[22]. Although the C-terminal anchoring domain of OM b5 does 
not bear any resemblance to known, N-terminal, mitochondrial 
targeting sequences, it is possible that it interacts with compo- 
nents of the mitochondrial import machinery, as has been 
shown for other proteins directed to the outer mitochondrial 
membrane [20,23]. If this turns out to be the case, OM bs will 
be a useful tool to define novel features required for recognition 
by outer mitochondrial membrane import receptors. As far as 
the insertion of tail-anchored proteins into the ER is concerned, 
recent evidence from cell-free studies on the v-snare synaptob- 
revin indicates a requirement for a trypsin-sensitive component 
of the ER, distinct from the components of the well-character- 
ized translocation machinery for secretory proteins [1]. Al- 
though such a protease-sensitive component has not been 
shown for the insertion of ER b5 [2], it is tempting to speculate 
that common proteins underlie the insertion of all ER-directed 
tail-anchored proteins. 
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